Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 120.50
-2.00 (-1.63%)
Apr 2, 2026, 1:30 PM CST
Grape King Bio Market Cap
Grape King Bio has a market cap or net worth of 17.85 billion as of April 2, 2026. Its market cap has decreased by -18.58% in one year.
Market Cap
17.85B
Enterprise Value
15.51B
Revenue
10.25B
Ranking
n/a
PE Ratio
14.75
Stock Price
120.50
Market Cap Chart
Since February 19, 1992, Grape King Bio's market cap has increased from 2.32B to 17.85B, an increase of 668.58%. That is a compound annual growth rate of 6.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 17.85B | -4.74% |
| Dec 31, 2025 | 18.74B | -15.38% |
| Dec 31, 2024 | 22.15B | -4.17% |
| Dec 29, 2023 | 23.11B | -7.14% |
| Dec 30, 2022 | 24.89B | 5.00% |
| Dec 30, 2021 | 23.70B | -2.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 31.13B |
| TTY Biopharm Company | 18.30B |
| ScinoPharm Taiwan | 17.91B |
| Synmosa Biopharma | 15.55B |
| YungShin Global Holding | 14.78B |
| Foresee Pharmaceuticals | 12.13B |
| Standard Chemical & Pharmaceutical | 11.42B |
| Alar Pharmaceuticals | 11.16B |